1 Stanley Druckenmiller Viking Therapeutics Trades

Stanley Druckenmiller's position in Viking Therapeutics is currently worth $14.8M. That's 0.37% of their equity portfolio (48th largest holding). The stake costed the investor $14.5M, netting the investor a gain of 2.5% so far.